Cure My Disease

Don't miss your cure!

Log in / Sign up

← Back to home

Alpine Immune Sciences Inc, A Subsidiary Of Vertex

Clinical trials sponsored by Alpine Immune Sciences Inc, A Subsidiary Of Vertex, explained in plain language.

Not yet finished but already full! 1

New hope for kidney disease: drug aims to cut protein leak and preserve function

Disease control Ongoing

This phase 3 study tests an investigational drug called povetacicept in 605 adults with IgA nephropathy, a kidney disease that can lead to kidney failure. The goal is to see if the drug reduces protein in the urine and slows the decline in kidney function compared to a placebo. P…

Phase: PHASE3 • Sponsor: Alpine Immune Sciences Inc, A Subsidiary of Vertex • Aim: Disease control

Last updated Apr 28, 2026 13:01 UTC